# US 2025/0367379 A1 · Concurrent multi-frequency impedance measurement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367379 A1
- Document ID: US20250367379A1
- Status: Published application
- Kind: A1
- Application number: 19/206,602
- Filed: 2025-05-13
- Published: 2025-12-04
- Earliest claimed: 2024-05-31
- Assignees: Medtronic MiniMed, Inc.
- Applicants: Medtronic Minimed, Inc.
- Inventors: Davy T. Tong; Timothy C. Kwa; Guangping Zhang; Evan M. Romo-Anselmo; Hsi C. Fusselman; Kiem H. Dang; Sarnath Chattaraj
- Web page: https://patentgrep.com/patent/US20250367379A1

## CPC

- A61B 5/1468: using chemical or electrochemical methods, e.g. by polarographic means
- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61B 5/4839: {combined with drug delivery}
- A61M 5/14248: {of the skin patch type}
- G01N 27/02: by investigating impedance
- G01N 27/026: {Dielectric impedance spectroscopy (electrochemical impedance spectroscopy for measuring corrosion G01N17/02)}
- G16H 20/17: delivered via infusion or injection
- G16H 40/63: for local operation
- A61B 5/7257: {using Fourier transforms}
- A61M 2005/1726: {the body parameters being measured at, or proximate to, the infusion site}
- A61M 2205/50: with microprocessors or computers
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2230/201: Glucose concentration
- A61M 2230/65: Impedance, e.g. conductivity, capacity
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Systems and methods for concurrent multi-frequency impedance measurements to characterize a substance of interest (e.g., analyte concentration) are disclosed herein. Generally, in some variations a method for characterizing a substance includes generating an input signal having a first set of frequency components across a plurality of frequencies, exciting an electrode arrangement with the input signal wherein the electrode arrangement is in contact with the substance. receiving an output signal from the excited electrode arrangement, the output signal having a second set of frequency components across the plurality of frequencies, determining an impedance signature of the substance across the plurality of frequencies, based on the first and second sets of frequency components, and characterizing the substance based on the impedance signature.

## Claims

### Claim at position 1

1-97. (canceled)

### Claim 98

A method for identifying concentration of an analyte, the method comprising:
generating an input signal having a first set of frequency components across a plurality of frequencies;
exciting an electrode arrangement with the input signal, wherein the electrode arrangement is in contact with the analyte;
receiving an output signal from the excited electrode arrangement, the output signal having a second set of frequency components across the plurality of frequencies;
determining an impedance signature of the analyte across the plurality of frequencies, based on the first and second sets of frequency components; and
determining a concentration of the analyte based on the impedance signature.

### Claim 99 (depends on 98)

The method of claim 98, wherein the input signal is a non-sinusoidal wave.

### Claim 100 (depends on 98)

The method of claim 98, wherein the input signal has an operating excitation voltage range of +1.23 V to −1.23 V.

### Claim 101 (depends on 98)

The method of claim 98, wherein determining the impedance signature of the analyte comprises:
decomposing the input signal into the first set of frequency components;
decomposing the output signal into the second set of frequency components; and
determining an impedance of the analyte at each of the plurality of frequencies based on a comparison of the first and second sets of frequency components.

### Claim 102 (depends on 101)

The method of claim 101, wherein decomposing the input signal comprises applying a first Fourier transform to the input signal, and decomposing the output signal comprises applying a second Fourier transform to the output signal.

### Claim 103 (depends on 98)

The method of claim 98, wherein determining the concentration of the analyte comprises determining compositional information of the analyte.

### Claim 104 (depends on 98)

The method of claim 98, wherein the electrode arrangement is in an analyte delivery device.

### Claim 105 (depends on 104)

The method of claim 104, further comprising controlling delivery of the analyte to a user, based at least in part on the determined concentration of the analyte.

### Claim 106 (depends on 105)

The method of claim 105, wherein controlling delivery of the analyte comprises:
determining a volume of fluid including the analyte to be delivered to the user; and
delivering the determined volume of fluid to the user.

### Claim 107 (depends on 105)

The method of claim 105, wherein controlling delivery of the analyte comprises providing an alert communicating an indication of the determined concentration of the analyte.

### Claim 108 (depends on 98)

The method of claim 98, wherein the electrode arrangement is in an analyte monitoring device.

### Claim 109

A system for measuring concentration of an analyte, the system comprising:
an electrode arrangement in contact with a fluid including the analyte;
a processor; and
a memory device operably coupled to the processor and storing instructions that, when executed by the processor, cause the system to perform operations comprising:
generating an input signal having a first set of frequency components across a plurality of frequencies;
exciting the electrode arrangement with the input signal;
receiving an output signal from the excited electrode arrangement, the output signal having a second set of frequency components across the plurality of frequencies;
determining an impedance signature of the analyte across the plurality of frequencies, based on the first and second sets of frequency components; and
determining a concentration of the analyte based on the impedance signature.

### Claim 110 (depends on 109)

The system of claim 109, wherein the input signal is a non-sinusoidal wave.

### Claim 111 (depends on 109)

The system of claim 109, wherein determining the impedance signature of the analyte comprises:
decomposing the input signal into the first set of frequency components;
decomposing the output signal into the second set of frequency components; and
determining an impedance of the analyte at each of the plurality of frequencies based on a comparison of the first and second sets of frequency components.

### Claim 112 (depends on 109)

The system of claim 109, wherein determining the concentration of the analyte comprises determining compositional information of the analyte.

### Claim 113 (depends on 109)

The system of claim 109, wherein the system comprises an analyte delivery device.

### Claim 114 (depends on 113)

The system of claim 113, wherein the analyte delivery device comprises an insulin pump.

### Claim 115 (depends on 113)

The system of claim 113, wherein the analyte delivery device comprises a patch pump device.

### Claim 116 (depends on 13)

The system of claim 13, wherein the analyte delivery device comprises a tethered pump device.

### Claim 117 (depends on 13)

The system of claim 13, wherein the analyte delivery device comprises an insulin pen.
